GILD

SELL

Gilead Sciences, Inc.· Healthcare

Market Cap: $190.4B

Score
31
31

ANDAMENTO PREZZO

$153.57+63.75%

Prezzi aggiornati al 21 ott 2026

INDICATORI TECNICI

RSI (14 giorni)

59Forte
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)

MACD (12,26,9)

↑ RialzistaMACD 2.158 · Signal 1.688 · Hist 0.470

Prezzo vs Medie Mobili

SMA 20
$150.40-55.6%
SMA 50
$147.99-54.9%
SMA 200
$137.84-51.6%
Bollinger Band %B0% — Vicino lower band
$143mid $150$158
Volume ratio (vs media 20gg)1.10x

BREAKDOWN SCORE (0 → 100)

P/E Trailing0.0 / 25
FCF Yield20.6 / 25
Price/Book0.0 / 15
EPS0.0 / 15
Debt/Equity0.0 / 10
Dividendo5.0 / 5
Momentum 90gg5.0 / 5

FONDAMENTALI

Clicca i per spiegazione✓ 2 ok~ attenzione✗ 3 negativi
P/E Trailing
—
~P/E Forward
15.4x
✗P/B
16.1x
~FCF Yield
5.0%
✗EPS TTM
-2,60
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
10.2%
✗Debt/Equity
2.2x
Market Cap
$190.4B
✓Div. Yield
214.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare

Aggiornato: 22 ott 2026